93 related articles for article (PubMed ID: 5586190)
21. [Experimental studies of the relations between alpha-tocopherol and the ovary. Behavior of ovarian ascorbic acid depletion activity during E hypervitaminosis and avitaminosis].
Oppo GT; Barbanti-Silva C; Segre A
Riv Ital Ginecol; 1967 Dec; 51(12):797-820. PubMed ID: 5619845
[No Abstract] [Full Text] [Related]
22. [Radio-immunologic determination of plasma lutenizing hormone in sheep. Comparison with the biologic determination of LH by the diminution of ovarian ascorbic acid, and example of the application to measure of the blood LH in ewes].
Pelletier J; Kann G; Dolais J; Rosselin G
C R Acad Hebd Seances Acad Sci D; 1968 Jun; 266(25):2352-4. PubMed ID: 4971515
[No Abstract] [Full Text] [Related]
23. Purification and physicochemical properties of bovine luteinizing hormone (LH) and comparison between bull and cow LH-preparations.
Courte C; Hurault M; Clary C; De la Llosa P; Jutisz M
Gen Comp Endocrinol; 1972 Apr; 18(2):284-91. PubMed ID: 5062787
[No Abstract] [Full Text] [Related]
24. [Experiences with Parlow's ascorbic acid test].
Breckwoldt M; Czygan PJ
Z Geburtshilfe Gynakol; 1967 Oct; 167(3):329-36. PubMed ID: 5597696
[No Abstract] [Full Text] [Related]
25. Studies on the ovarian ascorbic acid depletion test (OAAD) for luteinizing hormone (LH).
Yokota N; Igarashi M; Matsumoto S
Endocrinol Jpn; 1965 Jun; 12(2):83-91. PubMed ID: 5897655
[No Abstract] [Full Text] [Related]
26. An improved method of ascorbic acid measurement in the ovarian ascorbic acid depletion assay.
Smith JA
J Endocrinol; 1972 Nov; 55(2):461-2. PubMed ID: 4636363
[No Abstract] [Full Text] [Related]
27. Effects of luteinizing hormone and vasopressin injected into the ovarian bursa on ovarian ascorbic acid concentration.
Ishii S
Endocrinol Jpn; 1971 Jun; 18(3):263-6. PubMed ID: 5172023
[No Abstract] [Full Text] [Related]
28. [Research on the luteinizing action of vitamin A: behavior of ovarian ascorbic acid depletion activity in puberal and impuberal rats treated with axerophthol acetate].
Oppo GT; Barbanti-Silva C; Morelli L
Minerva Ginecol; 1968 Mar; 20(5):451-60. PubMed ID: 5738745
[No Abstract] [Full Text] [Related]
29. [A modification of the ascorbic acid depletion tests (OAAD) for evaluation, for clinical purposes, of the luteinizing hormone].
Mondina R; Polvani F
Ann Ostet Ginecol Med Perinat; 1968 Feb; 90(2):122-9. PubMed ID: 5751247
[No Abstract] [Full Text] [Related]
30. Ascorbic acid depletion activity of the pituitary of the female anole.
Bratcher JB; Kent GC
Proc Soc Exp Biol Med; 1971 Mar; 136(3):839-41. PubMed ID: 5555377
[No Abstract] [Full Text] [Related]
31. A modified ovarian cholesterol depletion assay for luteinizing hormone.
Zarrow MX; Clark JH
J Endocrinol; 1969 Mar; 43(3):459-64. PubMed ID: 4305313
[No Abstract] [Full Text] [Related]
32. Studies on pituitary gonadotrophins in human plasma. II. Follicle-stimulating and luteinizing hormone in male and postmenopausal plasma.
Keller PJ
Acta Endocrinol (Copenh); 1966 Jul; 52(3):348-56. PubMed ID: 6013144
[No Abstract] [Full Text] [Related]
33. A new bioassay for luteinizing hormone.
Rees LH; Holdaway IM; McNeilly AS; Chard T
J Endocrinol; 1973 Jul; 58(1):18. PubMed ID: 4737337
[No Abstract] [Full Text] [Related]
34. [The mechanism of action of synthetic antiovular drugs. Experimental studies with mestranol, medroxyprogesterone and norethindrone].
Oppo GT; Barbanti-Silva C; Segre A
Riv Ital Ginecol; 1968 May; 52(5):389-410. PubMed ID: 5740572
[No Abstract] [Full Text] [Related]
35. Some observations on the dose-response curve of the ovarian ascorbic acid depletion test for luteinizing hormone.
Bell ET; Mukerji S
J Endocrinol; 1965 Oct; 33(2):325-6. PubMed ID: 5891675
[No Abstract] [Full Text] [Related]
36. Pentose phosphate pathway and ovarian steroidogenesis in rats following oxythiamine treatment.
Deb C; Sen Gupta J; Ghosh S; Dey SK
Endokrinologie; 1973 Oct; 62(2):142-9. PubMed ID: 4778774
[No Abstract] [Full Text] [Related]
37. [Experimental findings on spleno-endocrine correlations. Influence of splenectomy on blood luteinizing activity in rats].
Oppo GT; Segre A; Barbanti-Silva C; Citti U
Quad Clin Ostet Ginecol; 1969 Jan; 24(1):43-62. PubMed ID: 5404720
[No Abstract] [Full Text] [Related]
38. Measurement of luteinizing hormone by the hyperemia and ovarian ascorbic acid depletion assays.
Reichert LE
Endocrinology; 1966 Apr; 78(4):815-8. PubMed ID: 5948313
[No Abstract] [Full Text] [Related]
39. [Ascorbic acid content of the human ovary].
Wagner F; Hofmann KD; Preibsch W; Koob G
Zentralbl Gynakol; 1970 Aug; 92(33):1060-1. PubMed ID: 5528178
[No Abstract] [Full Text] [Related]
40. Bioassay of antigonadotrophic sera. 3. Assay of the human follicle stimulating hormone (FSH) neutralising potency.
Robyn C; Diczfalusy E
Acta Endocrinol (Copenh); 1968 Oct; 59(2):277-97. PubMed ID: 5754973
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
